Testing effectiveness (Phase 2)Study completedNCT05981846
What this trial is testing
A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19
Who this might be right for
SARS CoV 2 InfectionInfluenza, Human
Hipra Scientific, S.L.U 279